Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX was delisted on the 15th of June, 2023.
2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.
74% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $51.5M
99% less funds holding
Funds holding: 219 → 2 (-217)
100% less capital invested
Capital invested by funds: $4.35B → $1.98M (-$4.35B)
100% less funds holding in top 10
Funds holding in top 10: 13 → 0 (-13)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 216
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$351M |
| 2 |
BlackRock
New York
|
-$300M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$292M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$204M |
| 5 |
7IH
72 Investment Holdings
Stamford,
Connecticut
|
-$198M |
RXDX Hedge Fund Activity: Q2 2023 in Review
2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.
Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.
- 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
- Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
- The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.
Based on aggregated 13F filings for Q2 2023.